Suppr超能文献

抗微管相关蛋白-1单克隆抗体在培养的哺乳动物细胞的细胞核和中心体中产生免疫荧光斑点。

Monoclonal antibody against microtubule associated protein-1 produces immunofluorescent spots in the nucleus and centrosome of cultured mammalian cells.

作者信息

Sato C, Nishizawa K, Nakamura H, Komagoe Y, Shimada K, Ueda R, Suzuki S

出版信息

Cell Struct Funct. 1983 Sep;8(3):245-54. doi: 10.1247/csf.8.245.

Abstract

A monoclonal antibody was raised against the highest molecular weight protein associated with microtubules (MAP-1). Its specific binding to MAP-1 was determined by immunoblotting of the gel electrophoretogram of microtubule proteins prepared from porcine brain. The antibody reacted only with MAP-1, not with MAP-2, tau or tubulin. Indirect immunofluorescent staining by this antibody showed bright intranuclear spots, the centrosome and the faint meshwork of the cytoplasm in several types of cultured mammalian cells; HeLa, PtK2, human skin fibroblasts, mouse melanoma cells, Chinese hamster ovary cells. The nuclear spots in the interphase cells, were replaced by diffuse enhanced fluorescence throughout the cell except for chromosomes during mitosis. They reappeared in late telophase, first in the cytoplasm, late in the nucleus. The punctate pattern of nuclear immunofluorescence was not affected by microtubule-depolymerizing agents. The result that it persisted on residual cell structures after extraction with a high salt concentration buffer containing Triton X-100 followed by digestion with DNase I and RNase A suggests that the antigen is associated with the nuclear skeleton.

摘要

制备了一种针对与微管相关的最高分子量蛋白质(MAP-1)的单克隆抗体。通过对从猪脑制备的微管蛋白凝胶电泳图进行免疫印迹,确定了其与MAP-1的特异性结合。该抗体仅与MAP-1反应,不与MAP-2、tau或微管蛋白反应。用此抗体进行间接免疫荧光染色显示,在几种培养的哺乳动物细胞中,如HeLa细胞、PtK2细胞、人皮肤成纤维细胞、小鼠黑色素瘤细胞、中国仓鼠卵巢细胞,有明亮的核内斑点、中心体和微弱的细胞质网络。间期细胞中的核斑点在有丝分裂期间除染色体外被整个细胞的弥漫性增强荧光所取代。它们在末期后期重新出现,首先出现在细胞质中,随后出现在细胞核中。核免疫荧光的点状模式不受微管解聚剂的影响。在用含有Triton X-100的高盐浓度缓冲液提取后,再用DNA酶I和RNA酶A消化,该模式仍保留在残留的细胞结构上,这一结果表明该抗原与核骨架相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验